Selected article for: "patient SARS positive test and SARS positive test"

Author: Sherwood, Karen R.; Nicholl, David D. M.; Fenninger, Franz; Wu, Vivian; Wong, Paaksum; Benedicto, Vince; Cina, Davide P.; Wang, Meng; Pobran, Taylor D.; De Marco, Mari L.; Márquez, Anna Citlali; Jassem, Agatha N.; Sekirov, Inna; Morshed, Muhammad G.; Bardi, Mohammad; Sekhon, Mypinder; Keown, Paul; Kadatz, Matthew; Lan, James H.
Title: Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report
  • Cord-id: 5ad6lyb3
  • Document date: 2021_9_22
  • ID: 5ad6lyb3
    Snippet: To date there is limited data on the immune profile and outcomes of solid organ transplant recipients who encounter COVID-19 infection early post-transplant. Here we present a unique case where the kidney recipient’s transplant surgery coincided with a positive SARS-CoV-2 test and the patient subsequently developed symptomatic COVID-19 perioperatively. We performed comprehensive immunological monitoring of cellular, proteomic, and serological changes during the first 4 critical months post-inf
    Document: To date there is limited data on the immune profile and outcomes of solid organ transplant recipients who encounter COVID-19 infection early post-transplant. Here we present a unique case where the kidney recipient’s transplant surgery coincided with a positive SARS-CoV-2 test and the patient subsequently developed symptomatic COVID-19 perioperatively. We performed comprehensive immunological monitoring of cellular, proteomic, and serological changes during the first 4 critical months post-infection. We showed that continuation of basiliximab induction and maintenance of triple immunosuppression did not significantly impair the host’s ability to mount a robust immune response against symptomatic COVID-19 infection diagnosed within the first week post-transplant.

    Search related documents:
    Co phrase search for related documents
    • absolute count and luminex panel: 1
    • absolute count and lymphocyte subset: 1, 2, 3, 4, 5
    • accession number and acute phase: 1
    • acute phase and longitudinal assessment: 1, 2
    • acute phase and longitudinal evaluation: 1
    • acute phase and longitudinal sample: 1, 2
    • acute phase and luminex panel: 1
    • acute phase and lymphocyte subset: 1, 2, 3